EPS for Stamps.com Inc. (STMP) Expected At $1.33; Acorda Therapeutics (ACOR) Covered By 5 Bullish Analysts Last Week

August 1, 2017 - By Dolores Ford

Among 10 analysts covering Acorda Therapeutics (NASDAQ:ACOR), 5 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. Acorda Therapeutics had 19 analyst reports since August 25, 2015 according to SRatingsIntel. The firm has “Buy” rating by Aegis Capital given on Wednesday, January 6. The stock has “Hold” rating by J.P. Morgan on Tuesday, June 6. The firm has “Neutral” rating given on Tuesday, August 25 by JP Morgan. The stock of Acorda Therapeutics Inc (NASDAQ:ACOR) earned “Buy” rating by Janney Capital on Monday, March 13. The stock of Acorda Therapeutics Inc (NASDAQ:ACOR) earned “Buy” rating by Cowen & Co on Monday, June 5. The stock of Acorda Therapeutics Inc (NASDAQ:ACOR) earned “Outperform” rating by Cowen & Co on Tuesday, August 25. The rating was initiated by Aegis Capital on Tuesday, September 1 with “Buy”. The firm earned “Hold” rating on Thursday, July 27 by Cantor Fitzgerald. As per Tuesday, September 1, the company rating was initiated by Raymond James. JP Morgan upgraded Acorda Therapeutics Inc (NASDAQ:ACOR) on Wednesday, November 30 to “Overweight” rating. See Acorda Therapeutics Inc (NASDAQ:ACOR) latest ratings:

27/07/2017 Broker: Stifel Nicolaus Rating: Buy New Target: $30.0000 Maintain
27/07/2017 Broker: Cantor Fitzgerald Rating: Hold New Target: $18.0000 Maintain
11/07/2017 Broker: Jefferies Rating: Hold New Target: $22 Initiates Coverage On
06/06/2017 Broker: J.P. Morgan Rating: Hold New Target: $24.0000 Maintain
06/06/2017 Broker: Leerink Swann Rating: Hold
05/06/2017 Broker: Cowen & Co Rating: Buy New Target: $35.0000 Maintain
13/03/2017 Broker: Janney Capital Old Rating: Neutral New Rating: Buy Old Target: $23.00 New Target: $38.00 Upgrade
15/02/2017 Broker: Goldman Sachs Old Rating: Sell New Rating: Neutral Upgrade

Analysts expect Stamps.com Inc. (NASDAQ:STMP) to report $1.33 EPS on August, 2 after the close.They anticipate $0.15 EPS change or 10.14% from last quarter’s $1.48 EPS. STMP’s profit would be $22.54M giving it 27.84 P/E if the $1.33 EPS is correct. After having $1.20 EPS previously, Stamps.com Inc.’s analysts see 10.83% EPS growth. The stock decreased 0.54% or $0.8 during the last trading session, reaching $148.1. About shares traded. Stamps.com Inc. (NASDAQ:STMP) has risen 54.88% since August 1, 2016 and is uptrending. It has outperformed by 38.18% the S&P500.

Investors sentiment decreased to 0.93 in 2016 Q4. Its down 0.33, from 1.26 in 2016Q3. It dropped, as 30 investors sold Stamps.com Inc. shares while 79 reduced holdings. 34 funds opened positions while 67 raised stakes. 17.41 million shares or 4.59% less from 18.25 million shares in 2016Q3 were reported. Lord Abbett Lc has 0.1% invested in Stamps.com Inc. (NASDAQ:STMP) for 292,497 shares. Gotham Asset Ltd Liability reported 0.22% of its portfolio in Stamps.com Inc. (NASDAQ:STMP). Parametric Associate Limited Co accumulated 35,011 shares. Qs Invsts Lc accumulated 29,974 shares or 0.03% of the stock. Geneva Advsrs Lc invested in 13,615 shares or 0.03% of the stock. Aperio Group Ltd holds 8,560 shares or 0.01% of its portfolio. Principal Group Inc has 120,276 shares for 0.02% of their portfolio. Granahan Inc Ma has 128,200 shares. Ny State Common Retirement Fund has 37,364 shares for 0.01% of their portfolio. Geode Capital Mgmt Limited Com reported 123,219 shares. 143,900 are held by Cornerstone Incorporated. Park West Asset Mngmt Ltd Liability Com stated it has 310,000 shares. Sg Americas Limited Co accumulated 1,229 shares. Gamco Incorporated Et Al holds 0.02% in Stamps.com Inc. (NASDAQ:STMP) or 27,000 shares. The New York-based P2 Capital Prns Limited Liability has invested 8.9% in Stamps.com Inc. (NASDAQ:STMP).

Stamps.com Inc. is a provider of Internet mailing and shipping solutions in the United States. The company has market cap of $2.51 billion. The Firm offers mailing and shipping services and products to its clients under the Stamps.com, Endicia, ShipStation, ShipWorks and ShippingEasy brands. It has a 28.21 P/E ratio. It operates through the Internet Mailing and Shipping Services segment.

Since February 7, 2017, it had 0 insider purchases, and 21 insider sales for $50.63 million activity. 10,000 shares were sold by HUEBNER KYLE, worth $1.31 million. 5,000 shares were sold by WEISBERG SETH, worth $701,776 on Thursday, May 25. The insider MILLER LLOYD I III sold $2.65 million. 5,000 shares were sold by BORTNAK JAMES, worth $586,431. $165,420 worth of Stamps.com Inc. (NASDAQ:STMP) shares were sold by Khechfe Amine. MCBRIDE KENNETH THOMAS had sold 5,000 shares worth $658,820. On Wednesday, June 7 Clem John Roland sold $888,480 worth of Stamps.com Inc. (NASDAQ:STMP) or 6,170 shares.

Among 7 analysts covering Stamps.com (NASDAQ:STMP), 5 have Buy rating, 1 Sell and 1 Hold. Therefore 71% are positive. Stamps.com had 14 analyst reports since August 7, 2015 according to SRatingsIntel. The firm has “Buy” rating by Singular Research given on Monday, November 9. Northland Capital maintained Stamps.com Inc. (NASDAQ:STMP) rating on Friday, November 6. Northland Capital has “Outperform” rating and $100 target. The stock of Stamps.com Inc. (NASDAQ:STMP) earned “Sell” rating by Prescience Point on Thursday, July 14. The company was upgraded on Friday, November 6 by B. Riley & Co. The firm has “Buy” rating given on Monday, February 27 by Singular Research. B Riley maintained the shares of STMP in report on Friday, August 7 with “Neutral” rating. Sidoti upgraded the shares of STMP in report on Tuesday, January 12 to “Buy” rating. The stock of Stamps.com Inc. (NASDAQ:STMP) has “Neutral” rating given on Monday, November 9 by Sidoti. Singular Research initiated the stock with “Buy” rating in Monday, October 19 report.

Since February 9, 2017, it had 1 buy, and 5 selling transactions for $3.94 million activity. Blight Andrew sold $1.51 million worth of Acorda Therapeutics Inc (NASDAQ:ACOR) on Thursday, February 9. LAWRENCE DAVID also sold $1.41M worth of Acorda Therapeutics Inc (NASDAQ:ACOR) on Thursday, February 9. Greene Barry E had sold 723 shares worth $16,376. Hindman Andrew A. had sold 7,704 shares worth $121,319. Another trade for 20,000 shares valued at $338,998 was bought by COHEN RON. Wasman Jane had sold 54,536 shares worth $1.22M on Thursday, February 9.

Acorda Therapeutics, Inc. is a biopharmaceutical company. The company has market cap of $1.01 billion. The Firm focuses on developing therapies that restore function and improve the lives of people with neurological disorders. It currently has negative earnings. As of December 31, 2016, the Company marketed three United States Food and Drug Administration -approved therapies, including Ampyra (dalfampridine) Extended Release Tablets, 10 milligram (mg), a treatment to improve walking in patients with multiple sclerosis (MS).

The stock decreased 0.23% or $0.05 during the last trading session, reaching $21.65. About shares traded. Acorda Therapeutics Inc (NASDAQ:ACOR) has declined 40.68% since August 1, 2016 and is downtrending. It has underperformed by 57.38% the S&P500.

Investors sentiment increased to 0.99 in 2016 Q4. Its up 0.10, from 0.89 in 2016Q3. It improved, as 17 investors sold Acorda Therapeutics Inc shares while 56 reduced holdings. 25 funds opened positions while 47 raised stakes. 46.53 million shares or 2.03% less from 47.49 million shares in 2016Q3 were reported. Mason Street Lc holds 0.01% or 10,077 shares in its portfolio. Spot Trading Limited Liability Corp reported 0.01% stake. New York-based Qs Invsts Limited Liability has invested 0.02% in Acorda Therapeutics Inc (NASDAQ:ACOR). Cornerstone Management Holding Limited Liability Company owns 73,900 shares for 0.01% of their portfolio. Pinebridge Invests L P invested in 0% or 5,866 shares. 103,431 are owned by Susquehanna International Gru Llp. Texas Permanent School Fund, Texas-based fund reported 33,634 shares. California Pub Employees Retirement reported 68,600 shares. Ameriprise Inc stated it has 275,880 shares. 49,202 are owned by Comerica Bank & Trust. Sg Americas Securities Ltd Liability holds 0% or 25,919 shares. Wellington Mngmt Group Llp accumulated 74,366 shares. Creative Planning accumulated 0% or 100 shares. Bnp Paribas Arbitrage Sa invested in 0% or 9,989 shares. Principal Group has invested 0.01% in Acorda Therapeutics Inc (NASDAQ:ACOR).